Stay updated on Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.

Latest updates to the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page
- Check2 days agoChange DetectedThe page’s interface/revision version was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a maintenance/software release rather than a change to the trial record itself.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision v3.5.0 was added to the history and v3.4.3 was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a history entry for Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.SummaryDifference0.1%

- Check74 days agoChange DetectedA new Revision: v3.4.2 was added to the record history, and the previously listed notices for funding lapsed (Revision: v3.4.1) were removed.SummaryDifference0.5%

- Check81 days agoChange DetectedNotice about government funding and NIH Clinical Center status is displayed, and the page shows revision v3.4.1 replacing v3.4.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cobimetinib+Atezolizumab in Melanoma Brain Metastases Clinical Trial page.